Skip to main content
Clinical Trials/ISRCTN04081530
ISRCTN04081530
Active, Not Recruiting
Phase 3

Migration and survival of all-polyethylene tibial components compared to the metal-backed modular components of the Triathlon CS Total Knee System. A RSA study

Stryker European Operations BV (Netherlands)0 sites60 target enrollmentSeptember 22, 2014

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Stryker European Operations BV (Netherlands)
Enrollment
60
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35099566/ (added 05/12/2023) 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29714073/ 2-year results (added 05/12/2023)

Registry
who.int
Start Date
September 22, 2014
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Stryker European Operations BV (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient is able to understand the meaning of the study and is willing to sign the EC approved, study specific Informed Patient Consent Form
  • 2\. Patients eligible and scheduled to undergo primary total knee replacement with any of the following indication
  • 2\.1\. Painful and disabled knee joint resulting from osteoarthritis (Ahlbäck stage II to V)
  • 2\.2\. One or more compartments are involved
  • 3\. Ability and willingness to follow instructions, including control of weight and activity level, and to return for follow\-up evaluations
  • 4\. A good nutritional state of the patient
  • 5\. The subject is a male or non\-pregnant female between 40 and 75 years of age

Exclusion Criteria

  • 1\. The subject is morbidly obese, defined as Body Mass Index (BMI) of \> 37
  • 2\. Previous major knee surgery
  • 3\. Patients who had a Total Knee Arthroplasty (TKA) on contralateral side within the last 6 months that is considered to have an unsatisfactory outcome. (Patients with contralateral TKA \> 3 months ago with good outcome can be included in the study)
  • 4\. Patients with other severe concurrent joint involvements that can affect their outcome
  • 5\. Patient has a flexion contracture of 15° and more
  • 6\. Patient has a varus/valgus contracture of 15° and more
  • 7\. The subject will be operated bilaterally
  • 8\. The subject has an active or suspected latent infection in or about the knee joint
  • 9\. Osteomyelitis
  • 10\. The subject has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device

Outcomes

Primary Outcomes

Not specified

Similar Trials